SWX:COPNPharmaceuticals
How Winlevi’s Europe Launch At Cosmo (SWX:COPN) Has Changed Its Investment Story
Cosmo N.V. has recently announced that its partner InfectoPharm has launched Winlevi, a first-in-class topical acne cream using clascoterone, in Austria and Germany following European Commission approval.
This rollout deepens Cosmo’s dermatology footprint in Europe and highlights the commercial potential of its role as exclusive global manufacturer of Winlevi.
We’ll now examine how Winlevi’s European rollout, including the Austria and Germany launches, could influence Cosmo’s broader...